Next Article in Journal
Enhancement of Leaf Gas Exchange and Primary Metabolites under Carbon Dioxide Enrichment Up-Regulates the Production of Secondary Metabolites in Labisia pumila Seedlings
Previous Article in Journal
Acylation of Heteroaromatic Amines: Facile and Efficient Synthesis of a New Class of 1,2,3-Triazolo[4,5-b]pyridine and Pyrazolo[4,3-b]pyridine Derivatives
Article Menu

Export Article

Open AccessArticle
Molecules 2011, 16(5), 3740-3760;

Crystallization Products of Risedronate with Carbohydrates and Their Substituted Derivatives

Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 612 42 Brno, Czech Republic
Zentiva k.s., U Kabelovny 130, 102 37 Prague 10, Czech Republic
Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
Faculty of Chemical Engineering, Institute of Chemical Technology, Technicka 5, 16628 Prague 6, Czech Republic
Preliminary results were presented at the Fourteenth Electronic Conference on Synthetic Organic Chemistry (ECSOC-14,, 1–30 November 2010.
Author to whom correspondence should be addressed.
Received: 7 February 2011 / Revised: 11 April 2011 / Accepted: 3 May 2011 / Published: 4 May 2011
(This article belongs to the Special Issue ECSOC-14)
Full-Text   |   PDF [978 KB, uploaded 18 June 2014]   |  


The gastrointestinal absorption of bisphosphonates is in general only about 1%. To address this problem mixtures of risedronate monosodium salt with twelve varied sugar alcohols, furanoses, pyranoses and eight gluco-, manno- and galactopyranoside derivatives as counterions were designed in an effort to prepare co-crystals/new entities with improved intestinal absorption. Crystalline forms were generated by means of kinetically and/or thermodynamically controlled crystallization processes. One hundred and fifty-two prepared samples were screened by means of FT-NIR and FT-Raman spectroscopy. No co-crystal was prepared, but noteworthy results were obtained. A new solid phase of risedronate monosodium salt generated in the presence of phenyl-β-d-galactopyranoside under thermodynamically controlled crystallization conditions was found and also characterized using solid state NMR spectroscopy, X-ray powder diffraction and differential scanning calorimetry. This new polymorph was named as form P. Interactions between risedronate monosodium salt and both carbohydrates were confirmed by means of molecular dynamics simulation. In the present study the relationships between the chemical structures of the studied compounds required for crystalline form change are discussed. View Full-Text
Keywords: risedronate; phenyl-β-d-galactopyranoside; polymorph P; FT-NIR; FT-Raman; CP/MAS NMR; XRPD; DSC risedronate; phenyl-β-d-galactopyranoside; polymorph P; FT-NIR; FT-Raman; CP/MAS NMR; XRPD; DSC

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Kos, J.; Pentakova, M.; Oktabec, Z.; Krejcik, L.; Mandelova, Z.; Harokova, P.; Hruskova, J.; Pekarek, T.; Dammer, O.; Tkadlecova, M.; Havlicek, J.; Vinsova, J.; Kral, V.; Dohnal, J.; Jampílek, J. Crystallization Products of Risedronate with Carbohydrates and Their Substituted Derivatives. Molecules 2011, 16, 3740-3760.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top